Angewandte Chemie International Edition
10.1002/anie.201900763
COMMUNICATION
Scheme 8. Orthogonal transformations of ambident substrates. ND = not
detected.
reaction with complex substrate 11g was scaled up to 2.23
grams, the desired product 12g was formed in 88% yield (2.19
g). For the drug molecule 13j, 10 mmol-scale (3.08 g) reaction
could give the difluoromethylated analog 14j in 79% yield. 2-
In
difluoromethylation of a wide range of carbon acids has been
developed, using TMSCF Br as a powerful difluorocarbene
conclusion,
a
general
method
for
efficient
(
Methoxy-2-naphthyl)-propanoic acid 15 (its S-isomer is called
naproxen), a nonsteroidal anti-inflammatory drug (NSAID) used
2
[
20]
to treat pain or inflammation , could be easily transformed to
ester 16. 16 could be efficiently difluoromethylated to 17, which
underwent hydrolysis to give 18. Thus, from the racemic
naproxen, we could easily obtain the difluoromethylated
naproxen 18 in three steps with 67% overall yield. These
reagent. This protocol is easy to scale up and amenable to the
late-stage modification of bioactive compounds. Compared with
2
other difluorocarbene reagents, TMSCF Br showed unique
reactivity towards C-nucleophiles in terms of the reaction
efficiency and substrate scope. We also demonstrated the
examples
further
showcase
the
potency
of
our
2
orthogonal reactivity of TMSCF Br towards ambident substrates,
difluoromethylation protocol in the late-stage difluoromethylation
of bioactive compounds for drug discovery.
which has never been exemplified by other difluorocarbene
reagents. This work not only provides a facile approach to
3
access the difluoromethylated analog of sp - and sp-hybridized
C-nucleophiles, it also opens a new avenue for the orthogonal
reactivity study in difluorocarbene chemistry. Further
investigations in this direction are underway in our laboratory.
Acknowledgements
This work was supported by the National Key Research and
Development Programof China (Nos. 2015CB931900,
2016YFB0101200), the National Natural Science Foundation of
China (Nos. 21632009, 21421002, 21472221), the Key
Programs of the Chinese Academy of Sciences (No. KGZD-EW-
T08), the Key Research Program of Frontier Sciences of CAS
(
No. QYZDJ-SSW-SLH049), and Shanghai Science and
Technology program (No. 16QA1404600).
Scheme 7. Late-stage difluoromethylation of bioactive and complex molecules
in gram scale.
Keywords: difluorocarbene • difluoromethylation • carbon acids
•
bromodifluoromethyltrimethylsilane • synthetic method
2
Due to the unique feature of TMSCF Br that can generate
difluorocarbene under different conditions, we envisioned that its References
orthogonal reactivity towards different functional groups in
[
1]
a) W. K. Hagmann, J. Med. Chem. 2008, 51, 4359; b) J. Wang, M.
Sanchez-Rosello, J. L. Acena, C. del Pozo, A. E. Sorochinsky, S.
Fustero, V. A. Soloshonok, H. Liu, Chem. Rev. 2014, 114, 2432; c) I.
Ojima, Fluorine in Medicinal Chemistry and Chemical Biology, Wiley-
Blackwell, Chichester, U.K., 2009; d) E. P. Gillis, K. J. Eastman, M. D.
Hill, D. J. Donnelly, N. A. Meanwell, J. Med. Chem. 2015, 58, 8315.
a) C. D. Sessler, M. Rahm, S. Becker, J. M. Goldberg, F. Wang, S. J.
Lippard, J. Am. Chem. Soc. 2017, 139, 9325; b) J. A. Erickson, J. I.
McLoughlin, J. Org. Chem. 1995, 60, 1626; c) N. A. Meanwell, J. Med.
Chem. 2011, 54, 2529.
ambident substrates under different conditions could be possible
Scheme 8). For alkyne 7b, under basic conditions, only the
difluoromethylated alkyne 8b was formed in 84% yield; while
(
o
with nBu
4
NBr being used as a catalyst at 110 C, the
[
21]
difluorocyclopropene 19 was formed exclusively in 94% yield.
[2]
For the vinyl-containing ester 1h, the acidic C-H bond was
selectively difluoromethylated to give 2h in 78% yield under
basic conditions, and the difluorocyclopropane 20 was
exclusively generated in 89% yield at high temperature under
neutral conditions. To the best of our knowledge, this type of
orthogonal reactivity has never been exhibited by other
[3]
[4]
S. Boland, J. Alen, A. Bourin, K. Castermans, N. Boumans, L. Panitti, J.
Vanormelingen, D. Leysen, O. Defert, Bioorg. Med. Chem. Lett. 2014,
2
4, 4594.
X.-Q. Li, T. B. Andersson, M. Ahlstrom, L. Weidolf, Drug Metab Dispos
004, 32, 821.
2
[
5]
a) W. Zhang, Y. Wang, Tetrahedron Lett. 2018, 59, 1301; b) D. E.
Yerien, S. Barata-Vallejo, A. Postigo, Chem. Eur. J. 2017, 23, 14676; c)
Q. Liu, C. Ni, J. Hu, Natl Sci Rev 2017, 4, 303; d) J. Rong, C. Ni, J. Hu,
Asian J. Org. Chem 2017, 6, 139; e) C. Ni, J. Hu, Chem. Soc. Rev.
2
difluorocarbene sources, which features TMSCF Br as a unique
[
22]
and versatile difluorocarbene reagent.
2016, 45, 5441; f) J. Hu, W. Zhang, F. Wang, Chem. Commun. 2009,
7465; g) G. Prakash, S. Krishnamoorthy, Synthesis 2017, 49, 3394; h)
Z. Feng, Y. L. Xiao, X. Zhang, Acc. Chem. Res. 2018, 51, 2264; i) M.
Takashi, I. Junji, Chem. Lett. 2004, 33, 1206; j) G. K. Prakash, R. Mogi,
G. A. Olah, Org. Lett. 2006, 8, 3589; k) H. Dang, A. M. Whittaker, G.
Lalic, Chem. Sci. 2016, 7, 505.
[
[
6]
7]
a) J. Hu, C. Ni, Synthesis 2014, 46, 842; b) C. Ni, M. Hu, J. Hu, Chem.
Rev. 2015, 115, 765; c) A. D. Dilman, V. V. Levin, Acc. Chem. Res.
2018, 51, 1272; d) F. Wang, W. Zhang, J. Zhu, H. Li, K.-W. Huang, J.
Hu, Chem. Commun. 2011, 47, 2411.
a) G. Liu, X. Wang, X. Lu, X.-H. Xu, E. Tokunaga, N. Shibata,
ChemistryOpen 2012, 1, 227; b) P. S. Fier, J. F. Hartwig, Angew. Chem.
Int. Ed. 2013, 52, 2092; Angew. Chem. 2013, 125, 2146; c) L. Li, F.
Wang, C. Ni, J. Hu, Angew. Chem. Int. Ed. 2013, 52, 12390; Angew.
Chem. 2013, 125, 12616; d) X. Y. Deng, J. H. Lin, J. Zheng, J. C. Xiao,
Chem. Commun. 2015, 51, 8805; e) Z. Feng, Q. Q. Min, X. Zhang, Org.
This article is protected by copyright. All rights reserved.